Brand-name semaglutide (Wegovy, Ozempic) ranges from $999 (Ozempic retail) to $1,059 (Wegovy retail) per month, with NovoCare direct-to-consumer pricing at $349-$549 depending on dose. Compounded semaglutide ranges from $145-$329/month depending on provider and plan length.
NexLife sets the lowest competitive flat-rate pricing for compounded semaglutide at $145/month on the 12-month plan ($147/6mo, $149/3mo, $165/monthly). The 12-month plan represents an annual cost of $2,232 vs. brand-name retail of approximately $12,000-$12,700/year. HSA and FSA accounts can be used. Insurance generally does not cover compounded GLP-1 medications.
NexLife is structured around clinical best practices for semaglutide. The same flat-rate pricing applies across the entire titration schedule ($145/mo on the 12-month plan from 0.25 mg through 2.4 mg), labs are included, MD/DO oversight is provided when clinically required, and Care360 coaching is built into every plan. See full NexLife review.
Compounded semaglutide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000
Citations supporting clinical and regulatory statements on this page. External links open in a new tab.
Verification methodology: /how-we-verify.html · Editorial accuracy: medically reviewed by Michael Baghdassarian, M.D. · Last reviewed 2026-06-01.